Overview Double-Blind, Placebo-Controlled Evaluation of the DMTS Status: Not yet recruiting Trial end date: 2022-11-01 Target enrollment: Participant gender: Summary The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty. Phase: Phase 2 Details Lead Sponsor: Teikoku Pharma USA, Inc.